OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The tumour glyco-code as a novel immune checkpoint for immunotherapy
Ernesto Rodríguez, Sjoerd Schetters, Yvette van Kooyk
Nature reviews. Immunology (2018) Vol. 18, Iss. 3, pp. 204-211
Closed Access | Times Cited: 363

Showing 1-25 of 363 citing articles:

Global view of human protein glycosylation pathways and functions
Katrine T. Schjoldager, Yoshiki Narimatsu, Hiren J. Joshi, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 12, pp. 729-749
Closed Access | Times Cited: 906

Mechanisms Controlling PD-L1 Expression in Cancer
Jong‐Ho Cha, Li-Chuan Chan, Chia‐Wei Li, et al.
Molecular Cell (2019) Vol. 76, Iss. 3, pp. 359-370
Open Access | Times Cited: 746

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 460

Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Stefan Mereiter, Meritxell Balmaña, Diana Campos, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 6-16
Open Access | Times Cited: 427

Siglecs as Immune Cell Checkpoints in Disease
Shiteng Duan, James C. Paulson
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 365-395
Open Access | Times Cited: 334

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
Li-Chuan Chan, Chia‐Wei Li, Weiya Xia, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3324-3338
Open Access | Times Cited: 290

Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Michal A. Stanczak, Shoib Sarwar Siddiqui, Marcel P. Trefny, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 11, pp. 4912-4923
Open Access | Times Cited: 247

Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
Joyce Lübbers, Ernesto Rodríguez, Yvette van Kooyk
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 220

Targeting Glycosylation: A New Road for Cancer Drug Discovery
Ana Filipa Costa, Diana Campos, Celso A. Reis, et al.
Trends in cancer (2020) Vol. 6, Iss. 9, pp. 757-766
Open Access | Times Cited: 208

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
Ernesto Rodríguez, Kelly Boelaars, Kari Brown, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 197

Immune checkpoints in the tumor microenvironment
Salman M. Toor, Varun Sasidharan Nair, Julie Decock, et al.
Seminars in Cancer Biology (2019) Vol. 65, pp. 1-12
Closed Access | Times Cited: 196

Oligosaccharide Synthesis and Translational Innovation
Larissa B. Krasnova, Chi‐Huey Wong
Journal of the American Chemical Society (2019) Vol. 141, Iss. 9, pp. 3735-3754
Open Access | Times Cited: 172

Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
Stephanie van de Wall, Kim Santegoets, Eline J.H. van Houtum, et al.
Trends in Immunology (2020) Vol. 41, Iss. 4, pp. 274-285
Closed Access | Times Cited: 157

Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses
Heinz Laübli, Ajit Varki
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 4, pp. 593-605
Open Access | Times Cited: 152

Carbohydrate-based drugs launched during 2000−2021
Xin Cao, Xiaojing Du, Heng Jiao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 10, pp. 3783-3821
Open Access | Times Cited: 150

Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V. Mariño, Alejandro J. Cagnoni, Diego O. Croci, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 295-316
Open Access | Times Cited: 137

Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 119

FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer
Kayla Bastian, Emma Scott, David J. Elliott, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 455-455
Open Access | Times Cited: 116

Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 74

Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics
Tomislav Čaval, Frederico Alisson‐Silva, Flavio Schwarz
Theranostics (2023) Vol. 13, Iss. 8, pp. 2605-2615
Open Access | Times Cited: 42

Myeloid C-type lectin receptors in innate immune recognition
Caetano Reis e Sousa, Sho Yamasaki, Gordon D. Brown
Immunity (2024) Vol. 57, Iss. 4, pp. 700-717
Open Access | Times Cited: 27

Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey
Mengmeng Wang, Jianhui Zhu, David M. Lubman, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2018) Vol. 57, Iss. 4, pp. 407-416
Open Access | Times Cited: 150

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis
Ying‐Nai Wang, Heng‐Huan Lee, Jennifer L. Hsu, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 135

Glycans as Key Checkpoints of T Cell Activity and Function
Márcia S. Pereira, Inês Alves, Manuel M. Vicente, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 133

Page 1 - Next Page

Scroll to top